Chaudhary Kleem 4
4 · Checkmate Pharmaceuticals, Inc. · Filed Jan 15, 2021
Insider Transaction Report
Form 4
Chaudhary Kleem
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-14$2.62/sh+2,000$5,240→ 6,000 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-14−2,000→ 99,508 totalExercise: $2.62Exp: 2029-11-13→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vested and became exercisable on November 1, 2020 with the remainder to vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.